BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1091 related articles for article (PubMed ID: 21165148)

  • 1. Aptamer-based multiplexed proteomic technology for biomarker discovery.
    Gold L; Ayers D; Bertino J; Bock C; Bock A; Brody EN; Carter J; Dalby AB; Eaton BE; Fitzwater T; Flather D; Forbes A; Foreman T; Fowler C; Gawande B; Goss M; Gunn M; Gupta S; Halladay D; Heil J; Heilig J; Hicke B; Husar G; Janjic N; Jarvis T; Jennings S; Katilius E; Keeney TR; Kim N; Koch TH; Kraemer S; Kroiss L; Le N; Levine D; Lindsey W; Lollo B; Mayfield W; Mehan M; Mehler R; Nelson SK; Nelson M; Nieuwlandt D; Nikrad M; Ochsner U; Ostroff RM; Otis M; Parker T; Pietrasiewicz S; Resnicow DI; Rohloff J; Sanders G; Sattin S; Schneider D; Singer B; Stanton M; Sterkel A; Stewart A; Stratford S; Vaught JD; Vrkljan M; Walker JJ; Watrobka M; Waugh S; Weiss A; Wilcox SK; Wolfson A; Wolk SK; Zhang C; Zichi D
    PLoS One; 2010 Dec; 5(12):e15004. PubMed ID: 21165148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Highly multiplexed proteomic platform for biomarker discovery, diagnostics, and therapeutics.
    Mehan MR; Ostroff R; Wilcox SK; Steele F; Schneider D; Jarvis TC; Baird GS; Gold L; Janjic N
    Adv Exp Med Biol; 2013; 735():283-300. PubMed ID: 23402035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging Affinity-Based Proteomic Technologies for Large-Scale Plasma Profiling in Cardiovascular Disease.
    Smith JG; Gerszten RE
    Circulation; 2017 Apr; 135(17):1651-1664. PubMed ID: 28438806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unlocking biomarker discovery: large scale application of aptamer proteomic technology for early detection of lung cancer.
    Ostroff RM; Bigbee WL; Franklin W; Gold L; Mehan M; Miller YE; Pass HI; Rom WN; Siegfried JM; Stewart A; Walker JJ; Weissfeld JL; Williams S; Zichi D; Brody EN
    PLoS One; 2010 Dec; 5(12):e15003. PubMed ID: 21170350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beyond antibodies: new affinity reagents to unlock the proteome.
    Lollo B; Steele F; Gold L
    Proteomics; 2014 Mar; 14(6):638-44. PubMed ID: 24395722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of Large-Scale Aptamer-Based Proteomic Profiling to Planned Myocardial Infarctions.
    Jacob J; Ngo D; Finkel N; Pitts R; Gleim S; Benson MD; Keyes MJ; Farrell LA; Morgan T; Jennings LL; Gerszten RE
    Circulation; 2018 Mar; 137(12):1270-1277. PubMed ID: 29222138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-content affinity-based proteomics: unlocking protein biomarker discovery.
    Brody EN; Gold L; Lawn RM; Walker JJ; Zichi D
    Expert Rev Mol Diagn; 2010 Nov; 10(8):1013-22. PubMed ID: 21080818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of an Aptamer-Based Proteomics Assay (SOMAscan™) in Rat Cerebrospinal Fluid.
    Simats A; Ramiro L; Montaner J; García-Berrocoso T
    Methods Mol Biol; 2019; 2044():221-231. PubMed ID: 31432415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative selection and parallel characterization of aptamers.
    Cho M; Soo Oh S; Nie J; Stewart R; Eisenstein M; Chambers J; Marth JD; Walker F; Thomson JA; Soh HT
    Proc Natl Acad Sci U S A; 2013 Nov; 110(46):18460-5. PubMed ID: 24167271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High throughput and accurate serum proteome profiling by integrated sample preparation technology and single-run data independent mass spectrometry analysis.
    Lin L; Zheng J; Yu Q; Chen W; Xing J; Chen C; Tian R
    J Proteomics; 2018 Mar; 174():9-16. PubMed ID: 29278786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrated analysis of ultra-deep proteomes in cortex, cerebrospinal fluid and serum reveals a mitochondrial signature in Alzheimer's disease.
    Wang H; Dey KK; Chen PC; Li Y; Niu M; Cho JH; Wang X; Bai B; Jiao Y; Chepyala SR; Haroutunian V; Zhang B; Beach TG; Peng J
    Mol Neurodegener; 2020 Jul; 15(1):43. PubMed ID: 32711556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer protein biomarker discovery based on nucleic acid aptamers.
    Xiong H; Yan J; Cai S; He Q; Peng D; Liu Z; Liu Y
    Int J Biol Macromol; 2019 Jul; 132():190-202. PubMed ID: 30926499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Production of aptamers by cell-SELEX and their applications in cancer biomarker identification.
    Zhao J; He J; Zhong L; Huang Y; Zhao Y
    Discov Med; 2020; 29(158):159-167. PubMed ID: 33007191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aptamer-Based Proteomic Profiling Reveals Novel Candidate Biomarkers and Pathways in Cardiovascular Disease.
    Ngo D; Sinha S; Shen D; Kuhn EW; Keyes MJ; Shi X; Benson MD; O'Sullivan JF; Keshishian H; Farrell LA; Fifer MA; Vasan RS; Sabatine MS; Larson MG; Carr SA; Wang TJ; Gerszten RE
    Circulation; 2016 Jul; 134(4):270-85. PubMed ID: 27444932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aptamers and the next generation of diagnostic reagents.
    Thiviyanathan V; Gorenstein DG
    Proteomics Clin Appl; 2012 Dec; 6(11-12):563-73. PubMed ID: 23090891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel proteomic technologies to address gaps in pre-clinical ovarian cancer biomarker discovery efforts.
    Jordan HA; Thomas SN
    Expert Rev Proteomics; 2023; 20(12):439-450. PubMed ID: 38116719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Massively parallel interrogation of aptamer sequence, structure and function.
    Fischer NO; Tok JB; Tarasow TM
    PLoS One; 2008 Jul; 3(7):e2720. PubMed ID: 18628955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optomechanical devices for deep plasma cancer proteomics.
    Kosaka PM; Calleja M; Tamayo J
    Semin Cancer Biol; 2018 Oct; 52(Pt 1):26-38. PubMed ID: 28867489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fractionation of the human plasma proteome for monoclonal antibody proteomics-based biomarker discovery 2: antigen identification by dot-blot array screening.
    Kovács A; Patai Z; Guttman A; Kádas J; Takács L; Kurucz I
    Electrophoresis; 2013 Nov; 34(20-21):3064-71. PubMed ID: 24027087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reproducibility and Variability of Protein Analytes Measured Using a Multiplexed Modified Aptamer Assay.
    Tin A; Yu B; Ma J; Masushita K; Daya N; Hoogeveen RC; Ballantyne CM; Couper D; Rebholz CM; Grams ME; Alonso A; Mosley T; Heiss G; Ganz P; Selvin E; Boerwinkle E; Coresh J
    J Appl Lab Med; 2019 Jul; 4(1):30-39. PubMed ID: 31639705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 55.